THE LATEST

Blue Health Insurers Reach Tentative Antitrust Settlement For $2.7 Billion

By Grabar Law | Sep 30, 2020

A tentative settlement has been negotiated with The Blue Cross Blue Shield insurance group to end a sweeping antitrust suit ...

Google’s Parent Alphabet Inc. Pledges $310 Million To Expand Diversity Efforts and Resolve Shareholder Litigation

By Grabar Law | Sep 30, 2020

Google's parent Alphabet Inc. pledged $310 million to expand diversity efforts and resolve shareholder litigation that alleged the company’s board ...

GRABAR LAW OFFICE INVESTIGATES POTENTIAL SHAREHOLDER DERIVATIVE ACTION ON BEHALF OF SHAREHOLDERS OF CABOT OIL & GAS CORPORATION (NYSE: COG)

By Grabar Law | Sep 18, 2020

The investigation focuses on whether the Company’s Board of Directors and/or officers breached their fiduciary duties. It is alleged that ...

Interior Molded Door Manufacturers Agree to Settle class actions for $75 million.

By Grabar Law | Sep 18, 2020

Defendant door makers Jeld-Wen and Masonite were accused of using their market dominance to fix the prices for indoor molded ...

Grabar Law Office Files Class Action Complaint Against Manufacturers of the Pharmaceutical Drug Bystolic®

By Grabar Law | Sep 8, 2020

The Class Action Complaint against AbbVie, Inc. (“AbbVie”); Allergan, Inc., Allergan Sales, LLC, and Allergan USA, Inc. (collectively, “Allergan”); and ...

Grabar Law Office Files Shareholder Derivative Action Against Officers and Directors Of FirstEnergy Corporation

By Grabar Law | Sep 4, 2020

As alleged in the Complaint, Defendants adopted a corporate policy of providing illegal payments to government officials, including Ohio Speaker ...

Grabar Law Office Files Shareholder Derivative Action Against Officers and Directors Of Under Armour, Inc.

By Grabar Law | Sep 1, 2020

This action arises out of the Defendants’ knowing, conscious, and intentional failure to: (1) adhere to accepted accounting principles regarding ...

Grabar Law Office Files Complaint To Compel Inspection Of Books And Records Of Fifth Third Bancorp (NASDAQ: FITB)

By Grabar Law | Aug 31, 2020

Plaintiff seeks to inspect books and records of Fifth Third to: (i) investigate potential wrongdoing, mismanagement, and breaches of fiduciary ...

Grabar Law Office Investigates Potential Shareholder Derivative Action on Behalf of Shareholders of Cabot Oil & Gas Corporation (NYSE: COG)

By Grabar Law | Aug 23, 2020

The investigation focuses on whether the Company’s Board of Directors and/or officers breached their fiduciary duties. It is alleged that ...

Grabar Law Office Files Antitrust Class Action Against Archer Daniels Midland Company For Manipulating the Price of Ethanol

By Grabar Law | Jul 27, 2020

As alleged in the complaint, by depressing prices at Argo, ADM depressed the revenues which Plaintiff and other ethanol producers ...

« Previous
1
…
6
7
8
9
10
…
15
Next »

Grabar Law Office In The News: Block’s Dorsey, Others Face Derivative Suit Over AML Woes

By Grabar Law | Feb 9, 2025

Officers and directors of Square and Cash App parent company Block Inc. face a shareholder derivative complaint over alleged anti-money ...

Grabar Law Office In The News: Micron CEO Accused Of Insider Trading In Fla. Investor Suit

By Grabar Law | Jan 24, 2025

A Micron Technology Inc. shareholder has accused the company CEO and several board members of insider trading after selling $70 million worth ...

GRABAR LAW OFFICE IN THE NEWS: Biotech Co.’s Facility Failures Lost Investors Money, Suit Says

By Grabar Law | Jan 10, 2025

The executives and directors of biotechnology company Humacyte Inc. have been hit with a shareholder derivative suit in North Carolina ...

GRABAR LAW OFFICE FILES ANTITRUST CLASS ACTION ON BEHALF OF MERCHANTS THAT ACCEPT VISA DEBIT CARDS

By Grabar Law | Nov 3, 2024

Grabar Law Office has filed a significant class action lawsuit against Visa Inc., alleging that Visa has systematically abused its ...

GRABAR LAW OFFICE FILES ANTITRUST CLASS ACTION ON BEHALF OF INDEPENDENT PHARMACIES AGAINST GOODRX AND MAJOR PBMS

By Grabar Law | Nov 3, 2024

Grabar Law Office has filed a class action lawsuit on behalf of independent pharmacies, challenging the anticompetitive practices of GoodRx ...

Grabar Law Office In the News: Pharma Co. Verrica Faces Derivative Suit Over FDA Inspection

By Grabar Law | Oct 23, 2024

Current and former officers and directors of dermatological medication maker Verrica Pharmaceuticals Inc. face a shareholder derivative action alleging the ...

Grabar Law Office In the News: Biotech Execs Face Investor Suit Over Medicare Claims

By Grabar Law | Sep 11, 2024

Executives and directors of biopharmaceutical company Ardelyx have been hit with a shareholder derivative suit in Massachusetts federal court alleging ...